Rapid quantification of mirtazapine and desmethyl mirtazapine in human plasma by LC-ESI-MS/MS: Application to a bioequivalence study

Journal of Saudi Chemical Society

Volumn 15, Issue 2, 2011, Pages 145-153

  Kuchekar, S R ^a   Kundlik, M L ^a   Zaware, B H ^b  

^a Padmashri Vikhe Patil College   (India)

^b New Arts Science and Commerce College Ahmednagar   (India)

Author keywords

Human plasma; LC MS MS; Mirtazapine and desmethyl mirtazapine; Positive ion electrospray

Indexed keywords

EID: 79951944014     PISSN: 13196103     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jscs.2010.07.001     Document Type: Article

References (18)

1. Baumann P., Jonzier-Perey M., Paus E., Nikisch G. Neuropsychobiology 2006, 54:179-181.
2. De Santana F.J.M., Cesarino E.J., Bonato P.S. Journal of Chromatography B 2004, 809:351-356.
3. De Santana F.J.M., Jabor V.A.P., Cesarino E.J., Lanchote V.L., Bonato P.S. Journal of Separation Science 2010, 33:268-276.
4. De Santana F.J.M., Lanchote V.L., Bonato P.S. Electrophoresis 2008, 29(18):3924-3932.
5. Dodd S., Burrows G.D., Norman T.R. Journal of Chromatography B 2000, 748:439-443.
6. Duverneuil C., de la Grandmaison G.L., de Mazcourt P., Alvarez J.C. Therapeutic Drug Monitoring 2003, 25:565-573.
7. FDA Guidance for Industry, Bioavailability Studies for Orally Administered Drug-Product - General Consideration, US Department of Health and Human Services, Food and Drug Administration Centre for Drug Administration Centre for Drug Evaluation and Research (CDER), 2000.
8. Guidance for Industry, Bioanalytical Method Validation, US Department of Health and Human Services, Food Drug administration Center for Drug Evaluation and Research (CDER), Centre for Veterinary Medicines (CVM), 2001. http://www.fda.govt./cder/guidance/4252fnl.htm.
9. Hong X., Yao Y., Hong S., Lei C. Chromatographia 2008, 68:65-70.
10. Mandrioli R., Pucci V., Sabbioni C., Bartoletti C., Fanali S., Raggi M.A. Journal of Chromatography A 2004, 1051:253-260.
11. Maris F.A., Dingler E., Niehues S. Journal of Chromatography B 1999, 721:309-316.
12. Physicians Desk Reference (PDR), 2007. Medicines Economics Inc., 61th ed., Montvale, NJ. http://www.PDR.net.
13. Pistos C., Koutsopoulou M., Panderi I. Analytica Chim Acta 2004, 514:15-26.
14. Ptaek P., Klima J., Macek J. Journal of Chromatography B 2003, 794:323-328.
15. Romiguieres T., Pehourcq F., Matoga M., Begaud B., Jarry C. Journal of Chromatography B 2002, 775:163-168.
16. Lancet 2000, 355:911-918. SNaRIs, NaSSAs, NaRIs.
17. Titier K., Castaing N., Scoto-Gomez E., Pehourcq F., Moore N., Molimard M. Therapeutic Drug Monitoring 2003, 25:581-587.
18. Wang X.Q., Pan X.J., Lin G.Y., Xiang Z., Wang X.B., Wu J.Z., Lin D. Fa Yi Xue Zhi 2009, 25(2):123-126.